Nationwide Survey on Seasonal Influenza Vaccination among Health Care Workers during the COVID-19 Pandemic in Greece: Determinants, Barriers and Peculiarities.

Ioanna Avakian, Katerina Dadouli, Lemonia Anagnostopoulos, Konstantinos Fotiadis, Athanasios Lianos, Paraskevi Mina, Christos Hadjichristodoulou, Varvara A Mouchtouri
Author Information
  1. Ioanna Avakian: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece. ORCID
  2. Katerina Dadouli: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece. ORCID
  3. Lemonia Anagnostopoulos: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece.
  4. Konstantinos Fotiadis: Hmathia General Hospital, Veria Hospital Unit, 59132 Veria, Greece. ORCID
  5. Athanasios Lianos: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece.
  6. Paraskevi Mina: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece.
  7. Christos Hadjichristodoulou: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece. ORCID
  8. Varvara A Mouchtouri: Laboratory of Hygiene and Epidemiology, Faculty of Medicine, University of Thessaly, 22 12 Papakyriazi Street, 41222 Larissa, Greece. ORCID

Abstract

BACKGROUND: Seasonal influenza vaccination (SIV) of health care workers (HCWs) is critical in protecting patients' and HCWs' health. Our objective was to examine HCW SIV coverage and related determinants.
METHODS AND MATERIALS: A nationwide cross-sectional questionnaire survey was conducted among HCWs during the first half of 2021. The questionnaire (online or paper-based) included knowledge, attitude and practice questions regarding SIV, COVID-19 vaccines and vaccination.
RESULTS: Out of 6500 questionnaires administered, 2592 were completed (response rate: 39.9%). SIV coverage reached 69.4% (95% CI: 67.6-71.2%) based on self-reported vaccine uptake. Nurses and administrative staff were found to be more skeptical and have lower vaccine acceptance in comparison with physicians (aOR = 0.66 and aQR = 0.59, respectively). Other SIV hesitancy risk factors included working in secondary health care (aOR = 0.59) and working in northern Greece (aQR = 0.66). Determinants for SIV acceptance included being or living with high-risk people due to medical history (aOR = 1.84 and aOR = 1.46, respectively), positive attitudes towards routine vaccinations (aOR: 1.86), knowledge about COVID-19 vaccines (aOR = 1.53) and COVID-19 vaccine uptake (aOR = 3.45). The primary reason for SIV refusal was low risk perception (58.7%).
CONCLUSIONS: SIV coverage (2020/2021) was relatively high, but remained far from formal recommendations. Specific occupational groups were skeptical and low-risk perception was the main reason for vaccine refusal. Targeted policies should be developed and enforced.

Keywords

References

  1. Nurs Older People. 2019 Mar 22;31(2):32-39 [PMID: 31468782]
  2. Hum Vaccin Immunother. 2021 Jul 3;17(7):2185-2189 [PMID: 33497309]
  3. Euro Surveill. 2010 Feb 11;15(6): [PMID: 20158980]
  4. Int J Environ Res Public Health. 2022 Feb 28;19(5): [PMID: 35270503]
  5. JAMA. 2020 Dec 8;324(22):2334 [PMID: 33136143]
  6. Influenza Other Respir Viruses. 2021 Jan;15(1):81-90 [PMID: 32666696]
  7. Acta Biomed. 2021 Mar 25;92(S2):e2021004 [PMID: 33855983]
  8. Hum Vaccin Immunother. 2022 Nov 30;18(5):2085461 [PMID: 35816683]
  9. J Health Commun. 2020 Sep 1;25(9):727-735 [PMID: 33186091]
  10. Crit Care. 2019 Jul 19;23(1):258 [PMID: 31324202]
  11. BMC Infect Dis. 2020 Nov 19;20(1):863 [PMID: 33213361]
  12. Hum Vaccin Immunother. 2022 Nov 30;18(6):2102354 [PMID: 35920744]
  13. BMC Public Health. 2021 Dec 23;21(1):2317 [PMID: 34949176]
  14. Am J Infect Control. 2022 Apr;50(4):369-374 [PMID: 35369936]
  15. Vaccine. 2011 Sep 2;29(38):6472-84 [PMID: 21756960]
  16. Vaccine. 2020 Jun 15;38(29):4609-4615 [PMID: 32430148]
  17. Vaccine. 2020 Oct 21;38(45):7049-7056 [PMID: 32980199]
  18. J Occup Health. 2022 Jan;64(1):e12376 [PMID: 36514845]
  19. J Glob Health. 2020 Dec;10(2):021102 [PMID: 33312512]
  20. PLoS One. 2018 Jun 7;13(6):e0198685 [PMID: 29879206]
  21. Behav Med. 2022 Sep 8;:1-8 [PMID: 36073723]
  22. Clin Med (Lond). 2017 Dec;17(6):484-489 [PMID: 29196347]
  23. Lancet. 2018 Mar 31;391(10127):1285-1300 [PMID: 29248255]
  24. Int J Environ Res Public Health. 2019 Oct 18;16(20): [PMID: 31635299]
  25. Am J Infect Control. 2019 Feb;47(2):133-138 [PMID: 30293741]
  26. Vaccine. 2022 Mar 15;40(12):1775-1782 [PMID: 35168841]
  27. Int J Occup Med Environ Health. 2022 Apr 11;35(2):127-139 [PMID: 34897290]
  28. Vaccines (Basel). 2022 May 12;10(5): [PMID: 35632522]
  29. Hum Vaccin Immunother. 2018 Mar 4;14(3):772-789 [PMID: 28787234]
  30. Am J Infect Control. 2021 Sep;49(9):1152-1157 [PMID: 33930516]
  31. Int J Environ Res Public Health. 2020 Nov 28;17(23): [PMID: 33260789]
  32. Int J Infect Dis. 2022 Dec;125:153-163 [PMID: 36328290]
  33. Int J Environ Res Public Health. 2022 May 26;19(11): [PMID: 35682083]
  34. Vaccine. 2010 Aug 23;28(37):5931-3 [PMID: 20637760]
  35. Vaccines (Basel). 2022 Jul 25;10(8): [PMID: 35893825]
  36. J Hosp Infect. 2021 Feb;108:168-173 [PMID: 33259883]
  37. Vaccines (Basel). 2022 Sep 13;10(9): [PMID: 36146596]
  38. Int J Environ Res Public Health. 2021 Oct 08;18(19): [PMID: 34639858]
  39. Int J Environ Res Public Health. 2022 Jan 30;19(3): [PMID: 35162609]
  40. Vaccine. 2022 Jan 28;40(4):562-567 [PMID: 34903376]
  41. Vaccines (Basel). 2023 Jan 11;11(1): [PMID: 36680004]
  42. Z Gesundh Wiss. 2022;30(10):2441-2448 [PMID: 34055572]
  43. MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1050-1054 [PMID: 30260944]
  44. Infect Dis Rep. 2021 Aug 28;13(3):757-762 [PMID: 34562996]
  45. MMWR Morb Mortal Wkly Rep. 2022 Oct 21;71(42):1319-1326 [PMID: 36264832]
  46. Hum Vaccin Immunother. 2021 Mar 4;17(3):664-672 [PMID: 33124954]
  47. Int J Environ Res Public Health. 2019 Mar 01;16(5): [PMID: 30832264]

MeSH Term

Humans
Influenza, Human
COVID-19 Vaccines
Influenza Vaccines
Cross-Sectional Studies
Seasons
Pandemics
Greece
COVID-19
Vaccination
Health Personnel
Surveys and Questionnaires
Attitude of Health Personnel

Chemicals

COVID-19 Vaccines
Influenza Vaccines

Word Cloud

Created with Highcharts 10.0.0SIV=aORvaccinationCOVID-19healthvaccine01influenzacarecoverageincludedvaccinesSeasonalworkersHCWsquestionnaireamongknowledgeuptakeskepticalacceptance66aQR59respectivelyriskworkingDeterminantsreasonrefusalperceptionseasonalBACKGROUND:criticalprotectingpatients'HCWs'objectiveexamineHCWrelateddeterminantsMETHODSANDMATERIALS:nationwidecross-sectionalsurveyconductedfirsthalf2021onlinepaper-basedattitudepracticequestionsregardingRESULTS:6500questionnairesadministered2592completedresponserate:399%reached694%95%CI:676-712%basedself-reportedNursesadministrativestafffoundlowercomparisonphysicianshesitancyfactorssecondarynorthernGreecelivinghigh-riskpeopleduemedicalhistory8446positiveattitudestowardsroutinevaccinationsaOR:8653345primarylow587%CONCLUSIONS:2020/2021relativelyhighremainedfarformalrecommendationsSpecificoccupationalgroupslow-riskmainTargetedpoliciesdevelopedenforcedNationwideSurveyInfluenzaVaccinationHealthCareWorkersPandemicGreece:BarriersPeculiarities

Similar Articles

Cited By